<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101500075</journal-id>
<journal-id journal-id-type="pubmed-jr-id">35764</journal-id>
<journal-id journal-id-type="nlm-ta">Nat Rev Cardiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat Rev Cardiol</journal-id>
<journal-title-group>
<journal-title>Nature reviews. Cardiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1759-5002</issn>
<issn pub-type="epub">1759-5010</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30410105</article-id>
<article-id pub-id-type="pmc">6377322</article-id>
<article-id pub-id-type="doi">10.1038/s41569-018-0108-7</article-id>
<article-id pub-id-type="manuscript">NIHMS1008509</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Dietary metabolism, the gut microbiome, and heart failure</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>W. H. Wilson</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Daniel Y.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hazen</surname>
<given-names>Stanley L.</given-names>
</name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Center for Microbiome &amp; Human Health, Lerner Research Institute, Cleveland Clinic</aff>
<aff id="A2"><label>2</label>Department for Cellular &amp; Molecular Medicine, Lerner Research Institute, Cleveland Clinic</aff>
<aff id="A3"><label>3</label>Center for Clinical Genomics, Heart and Vascular Institute, Cleveland Clinic</aff>
<aff id="A4"><label>4</label>Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic</aff>
<aff id="A5"><label>5</label>Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio.</aff>
<author-notes>
<corresp id="CR1">Address for correspondence: W. H. Wilson Tang, MD, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH 44195., Phone: (216) 444-2121, Fax: (216) 445-6165, <email>tangw@ccf.org</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>29</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2020</year>
</pub-date>
<volume>16</volume>
<issue>3</issue>
<fpage>137</fpage>
<lpage>154</lpage>
<!--elocation-id from pubmed: 10.1038/s41569-018-0108-7-->
<abstract id="ABS1">
<p id="P1">The contribution of gut microbiota to human health and diseases has expanded our insights into how microbial composition and function impacts the human host. Heart failure has long been associated with splanchnic circulation congestion, leading to bowel wall edema and impaired intestinal barrier function. This is thought to heighten the overall inflammatory state via enhanced bacterial translocation and the presence of bacterial products in the systemic circulation. Recently, several metabolites produced by gut microbes from dietary metabolism have also been linked to pathologies such as atherosclerosis, hypertension, heart failure, chronic kidney disease, obesity and type 2 diabetes mellitus. These findings suggested that the gut microbiome functions like an endocrine organ by generating bioactive metabolites that can directly or indirectly impact host physiology. We will discuss several newly discovered gut microbial metabolic pathways, including the production of trimethylamine (TMA)/ trimethylamine N-oxide (TMAO), short-chain fatty acids, and secondary bile acids, that appear to participate in the development and progression of cardiovascular diseases, including heart failure. We will also discuss the gut microbiome as a novel therapeutic target for the treatment of cardiovascular disease, and potential strategies for targeting intestinal microbial processes.</p>
</abstract>
<kwd-group>
<kwd>Gut microbiota</kwd>
<kwd>diet</kwd>
<kwd>heart failure</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>